2007International Journal of Internal MedicineRequires access

The research advances of neurofibromatosis type 1 pathogenesis

Zhou Lie-mi

Open publisher page 0 citations

Abstract

Neurofibromatosis 1(NF1)is a common genetic condition in which affected individuals are prone to the development of benign and malignant tumors.The NF1 tumor suppressor encodes a protein product neurofibromin,which functions as a negative regulator of RAS.Loss of neurofibromin expression in NF1-associated tumors or NF1-deficient mouse cells is associated with elevated RAS activity and increased cell proliferation.Despite this straightforward pathophysiologic association between RAS activity mediating by neurofibromin and tumorigenesis,recent insights from mouse and Drosophila modeling studies have suggested additional functions for neurofibromin and implicated NF1 heterozygosity in tumor formation.Lastly,NF1 knockout mouse studies have also demonstrated important roles for cooperating genetic changes that accelerate tumorigenesis as well as modifier genes that impact cancer susceptibility.

About this research paper

What this paper is about

Neurofibromatosis 1(NF1)is a common genetic condition in which affected individuals are prone to the development of benign and malignant tumors.The NF1 tumor suppressor encodes a protein product neurofibromin,which functions as a negative regulator of RAS.Loss of neurofibromin expression in NF1-associated tumors or NF1-deficient mouse cells is associated with elevated RAS activity and increased cell proliferation.Despite this straightforward pathophysiologic association between RAS activity mediating by neurofibromin and tumorigenesis,recent insights from mouse and Drosophila modeling studies have suggested additional functions for neurofibromin and implicated NF1 heterozygosity in tumor formation.Lastly,NF1 knockout mouse studies have also demonstrated important roles for cooperating genetic changes that accelerate tumorigenesis as well as modifier genes that impact cancer susceptibility.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Neurofibromatosis 1(NF1)is a common genetic condition in which affected individuals are prone to the development of benign and malignant tumors.The NF1 tumor suppressor encodes a protein product neurofibromin,which functions as a negative regulator of RAS.Loss of neurofibromin expression in NF1-associated tumors or NF1-deficient mouse cells is associated with elevated RAS activity and increased cell proliferation.Despite this straightforward pathophysiologic association between RAS activity mediating by neurofibromin and tumorigenesis,recent insights from mouse and Drosophila modeling studies have suggested additional functions for neurofibromin and implicated NF1 heterozygosity in tumor formation.Lastly,NF1 knockout mouse studies have also demonstrated important roles for cooperating genetic changes that accelerate tumorigenesis as well as modifier genes that impact cancer susceptibility.

Key concepts: Neurofibromin 1, Neurofibromatosis, Loss of heterozygosity, Carcinogenesis, Cancer research, Tumor suppressor gene, Suppressor, Biology

Related papers

Back to paper searchBrowse research topicsOriginal source
The research advances of neurofibromatosis type 1 pathogenesis — Research Paper | ScholarLens